Showing 41 - 60 results of 89 for search '"AstraZeneca"', query time: 0.06s Refine Results
  1. 41
  2. 42

    Update from Canadian Respirology Program Directors

    Published 2004-01-01
    “…Submitted by Elizabeth Tullis MD FRCPC Associate Professor of Medicine, Respirology Program Director, University of Toronto, Toronto, Ontario The Canadian Organization of Pulmonary Program Directors (COPPD) had their first meeting in Montreal on November 7, 2003, which was sponsored by an unrestricted educational grant from AstraZeneca Canada Inc. This meeting was held in conjunction with the Royal College of Physicians and Surgeons (RCPS) Respirology Subspecialty Committee meeting held on November 6, 2003, and with the first Canadian Division Directors meeting held on November 8, 2003.…”
    Get full text
    Article
  3. 43
  4. 44
  5. 45
  6. 46
  7. 47
  8. 48
  9. 49
  10. 50
  11. 51

    COVID-19 Booster Vaccines Administration in Different Countries by Angel Yun-Kuan Thye, Loh Teng-Hern Tan, Jodi Woan Fei Law, Vengadesh Letchumanan

    Published 2021-12-01
    “…This includes COVID-19 vaccines by Pfizer-BioNTech, Moderna, AstraZeneca, Janssen, Sinovac, and Sinopharm. Findings suggested that protection against COVID-19 provided by these vaccines may be waning or that the protection reduces against variants of concern (VOC) or even inadequate protection of the primary vaccination for some risk groups. …”
    Get full text
    Article
  12. 52
  13. 53

    Manifestaciones neurológicas asociadas a la vacuna contra COVID-19 by R. Alonso Castillo, J.C. Martínez Castrillo

    Published 2025-01-01
    “…La mayoría de casos publicados se produjeron en asociación temporal con la vacuna Pfizer (BNT162b2), seguida de la vacuna de AstraZeneca (ChAdOX1 nCoV-19). Conclusiones: Con los datos existentes actualmente no es posible establecer una relación de causalidad entre estos eventos adversos y las vacunas contra la COVID-19, ni calcular la frecuencia de aparición de estos trastornos. …”
    Get full text
    Article
  14. 54

    Neurological manifestations associated with COVID-19 vaccine by R. Alonso Castillo, J.C. Martínez Castrillo

    Published 2025-01-01
    “…Most of the published cases occurred in temporal association with the Pfizer vaccine (BNT162b2), followed by the AstraZeneca vaccine (ChAdOX1-S). Conclusions: It is not possible to establish a causal relationship between these adverse events and COVID-19 vaccines with the currently existing data, nor to calculate the frequency of appearance of these disorders. …”
    Get full text
    Article
  15. 55
  16. 56
  17. 57

    Anti-SARS-CoV-2 Antibody Level among Renal Transplant Recipients: A Case Report from Nepal by Kamal Ranabhat, Bhuvan Saud, Saroj Adhikari, Suraj Bhattarai, Rojan Adhikari, Bhoj Raj Luitel, Mahesh Raj Sigdel

    Published 2022-01-01
    “…All three cases had received two doses of Oxford-AstraZeneca COVID-19 vaccine AZD1222 (ChAdOx1). Serological analysis showed protective level of circulating antibodies in the blood of all three cases. …”
    Get full text
    Article
  18. 58
  19. 59

    A bad dream come true: ICT patent prosecution against EU competition law by Niccolò Galli

    Published 2022-11-01
    “…Regarding Art. 102 TFEU, the article concludes that the AstraZeneca jurisprudence on abusive patent prosecution is of a limited application for anti-competitive ICT patenting practices that essentially concern blocking patents. …”
    Get full text
    Article
  20. 60